Skip to content
Mahamaya Lifesciences logo

Mahamaya Lifesciences

544611 BSE
₹181.00

Close ·

P/E
60.33
View as Markdown
MCP
Close 4 Nov 2026 ₹181.00 +65.00 +56.0% since 18 Nov 2025
Start ₹116.00

Key Fundamentals

SMEFertilizers & AgrochemicalsChemicals

Price-based figures at the close · TTM

ROCE
20.00%
Debt to Equity
0.75
EPS (TTM)
₹3.00
Book Value
₹52.10
Market Cap
—
P/E (TTM)
60.33
P/B
3.47
ROE
19.30%
Dividend Yield
0.00%
EBITDA
₹34.30 Cr
52W High
₹205.05
52W Low
₹111.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

35 Poor

Data confidence 98/100

Category scores

Quality
32
Poor
Returns, margins, earnings quality 22% weight
Valuation
18
Poor
Cheap vs sector & own history 24% weight
Growth
67
Strong
Sales & profit trajectory 9% weight
Financial Health
40
Weak
Solvency, leverage, coverage 9% weight
Momentum
62
Good
Trend strength, vol-adjusted 12% weight
Ownership
29
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

1
  • Though the company is reporting repeated profits, it is not paying out dividend

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2611
OscillatorsBearish261
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
54.14
Neutral
MACD (12,26,9)
−0.68
Bullish
SMA (50)
180.69
Bullish
SMA (200)
174.65
Bullish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+33.91%
1Y+23.68%

Net profit

Net profit growth by window
3Y+61.98%
1Y+30.77%

Operating cash flow

Operating cash flow growth by window
3YTurned negative
1YTurned negative

Operating margin· change in pp

Operating margin growth by window
3Y+3.76 pp
1Y+0.93 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹90.00 Cr
Mar 2023₹137 Cr
Mar 2024₹161 Cr
Mar 2025₹266 Cr
Mar 2026₹329 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹3.00 Cr
Mar 2023₹4.00 Cr
Mar 2024₹5.00 Cr
Mar 2025₹13.00 Cr
Mar 2026₹17.00 Cr

Half-yearly Results

₹ Cr
544611 half-yearly results, ₹ crore
Particulars Sep 2024Sep 2025Mar 2026
Sales
146
163
166
Expenses
133
148
149
Operating Profit
13
15
17
OPM %
9%
9%
10%
Other Income
1
1
1
Interest
4
4
4
Depreciation
1
1
1
PBT
10
11
12
Tax %
27%
27%
35%
Net Profit
7
8
8
EPS (₹)
4.08
4.71
3.48

Profit & Loss

₹ Cr
544611 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
90
137
161
266
329
Expenses
84
128
148
241
296
Operating Profit
6
9
13
25
34
OPM %
7%
6%
8%
9%
10%
Other Income
0
0
1
1
1
Interest
2
3
6
7
8
Depreciation
1
1
1
2
2
PBT
4
5
7
17
24
Tax %
27%
26%
27%
26%
31%
Net Profit
3
4
5
13
17
EPS (₹)
1.99
2.74
3.81
7.21
7.06
Div. Payout %
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
544611 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
18
23
Reserves
14
18
23
32
99
Borrowings
19
24
55
58
91
Other Liabilities
21
34
33
81
98
Total Liabilities
56
78
112
188
310
Fixed Assets
20
21
21
27
35
CWIP
2
2
3
4
8
Investments
0
0
0
0
0
Other Assets
34
54
88
157
267
Total Assets
56
78
112
188
310

Cash Flow

₹ Cr
544611 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2
1
−23
0
−30
Investing
−3
−3
−2
−7
−16
Financing
1
2
24
9
81
Net Cash Flow
0
1
0
1
35
Free Cash Flow
−1
−2
−25
−5
−38
CFO/EBITDA
56
24
−162
6
−75

Ratios

544611 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
37
25
64
67
78
Inventory Days
93
109
137
167
194
Days Payable
83
87
61
92
88
Cash Conversion Cycle
47
48
140
142
184
Working Capital Days
8
9
14
29
49
ROCE %
—
20%
21%
26%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Mahamaya Lifesciences insights

53 extracted metrics across FY22–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 56.39%
  • Others 24.20%
  • Public 14.74%
  • FIIs 2.66%
  • DIIs 2.02%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Mahamaya Lifesciences

What does Mahamaya Lifesciences Ltd do?
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.
Where is Mahamaya Lifesciences Ltd (MAHALIFE) listed?
Mahamaya Lifesciences Ltd trades under code 544611 on the BSE.
Which sector does Mahamaya Lifesciences Ltd belong to?
Mahamaya Lifesciences Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the PE ratio of Mahamaya Lifesciences Ltd?
Mahamaya Lifesciences Ltd trades at a PE ratio of 60.33 as of 4 Nov 2026, on earnings per share of ₹3, against a book value of ₹52.1 per share.
What is the 52-week high and low of Mahamaya Lifesciences Ltd?
Over the last 52 weeks Mahamaya Lifesciences Ltd has traded between ₹111 and ₹205.05 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Mahamaya Lifesciences Ltd?
Mahamaya Lifesciences Ltd reported a return on equity of 19.30%. Its debt-to-equity ratio is 0.75.

Company Information

ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.

Website mahamayalifesciences.com/home
Listed 18 Nov 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544611.md for Mahamaya Lifesciences Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Fertilizer & Agrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month